HMRI Mid-Career Clinical Research Fellowship in Brain Cancer supported by Mark Hughes Foundation
Understanding and overcoming treatment resistance in brain tumours
Understanding and overcoming treatment resistance in brain tumours
Neuro Oncology is a niche area with around 500 newly diagnosed GLioma patients per year in NSW; however the care and support needs for this patient group are great, with high carer burden.
The CN2 will provide expert clinical consultancy to support high level care coordination for brain cancer patients requiring complex management.
The CN2 will provide expert clinical consultancy to support high level care coordination for brain cancer patients requiring complex management.
Co-sponsorship for Dr Terri Armstrong to speak at 11th COGNO Scientific Meeting in Brisbane 7-9 October 2018.
The CN2 will provide expert clinical consultancy to support high level care coordination for brain cancer patients requiring complex management.
Understanding and overcoming treatment resistance in brain tumours